Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco Dorsey Wright Momentum ETF
PDP
|
+$591M |
| 2 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$240M |
| 3 |
Boston Scientific
BSX
|
+$194M |
| 4 |
SCHW
Charles Schwab
SCHW
|
+$193M |
| 5 |
Clarivate
CLVT
|
+$158M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.25B |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$809M |
| 3 |
Willis Towers Watson
WTW
|
+$664M |
| 4 |
AstraZeneca
AZN
|
+$658M |
| 5 |
Microsoft
MSFT
|
+$573M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.19% |
| 2 | Financials | 6.48% |
| 3 | Consumer Discretionary | 5.4% |
| 4 | Healthcare | 5.05% |
| 5 | Communication Services | 4.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1901
First American
FAF
$7.98B
| $4.36M | ﹤0.01% |
65,011
-5,092
| -7% | -$340K |
|
1902
Sensata Technologies
ST
$6.69B
| $4.36M | ﹤0.01% |
79,574
-22,258
| -22% | -$1.28M |
|
1903
Cemex
CX
$16.9B
| $4.35M | ﹤0.01% |
607,085
+559,542
| +1,177% | +$4.42M |
|
1904
CALL
iShares MSCI United Kingdom ETF
EWU
$4.1B
| $4.35M | ﹤0.01% |
135,000
| – | – |
|
1905
PUT
Veeva Systems
VEEV
$33.8B
| $4.35M | ﹤0.01% |
15,100
+15,000
| +15,000% | +$4.76M |
|
1906
Strategy Inc
MSTR
$34.1B
| $4.33M | ﹤0.01% |
74,850
-69,250
| -48% | -$4.44M |
|
|
RDS.B
1907
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $4.33M | ﹤0.01% |
97,795
-243,249
| -71% | -$9.63M |
|
1908
PBF Energy
PBF
$7.49B
| $4.32M | ﹤0.01% |
333,409
-53,104
| -14% | -$551K |
|
1909
Exponent
EXPO
$3.19B
| $4.31M | ﹤0.01% |
38,110
-28,040
| -42% | -$3.02M |
|
1910
PUT
Novavax
NVAX
$1.21B
| $4.31M | ﹤0.01% |
+20,800
| New | +$4.58M |
|
1911
Restaurant Brands International
QSR
$26.2B
| $4.31M | ﹤0.01% |
70,373
-9,787
| -12% | -$627K |
|
1912
CALL
ZIM Integrated Shipping Services
ZIM
$2.96B
| $4.29M | ﹤0.01% |
+84,600
| New | +$3.95M |
|
1913
Affiliated Managers Group
AMG
$9.51B
| $4.29M | ﹤0.01% |
28,379
-7,820
| -22% | -$1.28M |
|
1914
Ironwood Pharmaceuticals
IRWD
$586M
| $4.29M | ﹤0.01% |
328,147
-210,044
| -39% | -$2.71M |
|
1915
Myriad Genetics
MYGN
$476M
| $4.28M | ﹤0.01% |
132,661
-70,370
| -35% | -$2.34M |
|
1916
Arrow Electronics
ARW
$10.5B
| $4.28M | ﹤0.01% |
38,147
-20,499
| -35% | -$2.37M |
|
1917
Vanguard FTSE All-World ex-US ETF
VEU
$64.8B
| $4.28M | ﹤0.01% |
70,159
-49,720
| -41% | -$3.13M |
|
1918
CALL
Emerson Electric
EMR
$81.6B
| $4.24M | ﹤0.01% |
45,000
| – | – |
|
1919
Relay Therapeutics
RLAY
$4B
| $4.23M | ﹤0.01% |
134,233
+11,007
| +9% | +$371K |
|
|
DSPG
1920
DELISTED
DSP Group Inc
DSPG
| $4.23M | ﹤0.01% |
193,130
+175,046
| +968% | +$3.13M |
|
1921
Halozyme
HALO
$9.88B
| $4.22M | ﹤0.01% |
103,725
-18,239
| -15% | -$763K |
|
1922
Moog Inc Class A
MOG.A
$12.4B
| $4.21M | ﹤0.01% |
55,278
-1,777
| -3% | -$139K |
|
1923
LGI Homes
LGIH
$1.35B
| $4.21M | ﹤0.01% |
29,655
-4,876
| -14% | -$770K |
|
1924
Ryder
R
$9.9B
| $4.2M | ﹤0.01% |
50,748
-20,350
| -29% | -$1.57M |
|
1925
PUT
Grocery Outlet
GO
$904M
| $4.19M | ﹤0.01% |
+194,200
| New | +$5.59M |
|
Similar funds
Citigroup's Q3 2021 Portfolio in Review
As of Q3 2021, Citigroup held 6,611 positions worth $169B, up 1.9% from $166B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Citigroup deployed $5.8B of net new capital in Q3 2021, opening 423 new positions and adding to 2,034 existing holdings. Its largest new stake was Hennessy Capital Investment Corp. VI Unit: 9,095,000 shares worth $90.5M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 12% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $2.25B trimmed.
- Citigroup's largest Q3 2021 buy was Hennessy Capital Investment Corp. VI Unit: 9,095,000 shares worth $90.5M.
- Citigroup added most to Invesco Dorsey Wright Momentum ETF in Q3 2021, an estimated $591M increase.
- Citigroup's biggest Q3 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.25B.
- Citigroup fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $809M.
- Citigroup's ten largest holdings make up 25% of its $169B portfolio in Q3 2021.
- Citigroup opened 423 new positions and closed 793 in Q3 2021.
- Citigroup's portfolio value rose 1.9% quarter-over-quarter to $169B.
Based on Citigroup's 13F filing for Q3 2021, filed 10 Nov 2021.